Pradžia › Cholesterolis › Texas
Cholesterolis klinikiniai tyrimai Texas
6 tyrimai dėl Cholesterolis ieško dalyvių vietose Texas.
Miestai Texas
Oficialus tyrimo tekstas (anglų kalba)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- PharmaTex Research, Amarillo
- Amarillo Heart Clinical Research Institute, Inc., Amarillo
- Austin Heart, Austin
- ir dar 8
Renkami dalyviai4 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Houston
- Research Site, Houston
- Research Site, Houston
- ir dar 3
Renkami dalyviai3 fazė
Amžius nuo 18 iki 130 · Visoms lytims · Atnaujinta 2026-09-10 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Synergy Group Medical LLC, Houston
- Synergy Group Medical LLC, Houston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-07-30 · NCT07610278A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Velocity Clinical Research Dallas, Dallas
- Valley Institute of Research, Rockwood Medical Clinic, Fort Worth
- Be Well Clinical Studies - Round Rock, Round Rock
- ir dar 3
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-07-22 · NCT07477704Multicomponent Intervention Study- Blood Donors With High Cholesterol
- UT Southwestern Medical Center, Dallas
Renkami dalyviai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-03-17 · NCT05693701Alirocumab in Patients on a Stable Dialysis Regimen
- Baylor Soltero CV Research, Dallas
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2020-02-12 · NCT03480568Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.